124 related articles for article (PubMed ID: 15871166)
1. High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland.
Kivelä PS; Krol A; Salminen MO; Geskus RB; Suni JI; Anttila VJ; Liitsola K; Zetterberg V; Miedema F; Berkhout B; Coutinho RA; Ristola MA
Scand J Infect Dis; 2005; 37(4):276-83. PubMed ID: 15871166
[TBL] [Abstract][Full Text] [Related]
2. [Distribution of recombinant human immunodeficiency virus type-1 CRF01_AE strains in China and its sequence variations in the env V3-C3 region].
Xing H; Liang H; Wan ZY; Chen X; Wei M; Ma PF; Guan Q; Quan Y; Hong KX; Shao YM
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):300-4. PubMed ID: 15498240
[TBL] [Abstract][Full Text] [Related]
3. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
[TBL] [Abstract][Full Text] [Related]
4. Closely related HIV-1 CRF01_AE variant among injecting drug users in northern Vietnam: evidence of HIV spread across the Vietnam-China border.
Kato K; Kusagawa S; Motomura K; Yang R; Shiino T; Nohtomi K; Sato H; Shibamura K; Nguyen TH; Pham KC; Pham HT; Duong CT; Nguyen TH; Bui DT; Hoang TL; Nagai Y; Takebe Y
AIDS Res Hum Retroviruses; 2001 Jan; 17(2):113-23. PubMed ID: 11177391
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 subtype B Tat gene activities and disease progression in HIV-1 CRF01_AE infection.
Niyasom C; Horthongkham N; Sreephiang A; Kantakamalakul W; Louisirirotchanakul S; Chuenchitra T; Sutthent R
Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):748-58. PubMed ID: 19842409
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 subtypes and response to combination antiretroviral therapy in Europe.
Bannister WP; Ruiz L; Loveday C; Vella S; Zilmer K; Kjaer J; Knysz B; Phillips AN; Mocroft A;
Antivir Ther; 2006; 11(6):707-15. PubMed ID: 17310815
[TBL] [Abstract][Full Text] [Related]
9. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
11. Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand.
Hu DJ; Subbarao S; Vanichseni S; Mock PA; Ramos A; Nguyen L; Chaowanachan T; Griensven Fv; Choopanya K; Mastro TD; Tappero JW
AIDS; 2005 Feb; 19(3):303-8. PubMed ID: 15718841
[TBL] [Abstract][Full Text] [Related]
12. Extensive and complex HIV-1 recombination between B', C and CRF01_AE among IDUs in south-east Asia.
Pang W; Zhang C; Duo L; Zhou YH; Yao ZH; Liu FL; Li H; Tu YQ; Zheng YT
AIDS; 2012 Jun; 26(9):1121-9. PubMed ID: 22333750
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan.
Lin YT; Lan YC; Chen YJ; Huang YH; Lee CM; Liu TT; Wong WW; Yang JY; Wang CT; Chen YM
J Infect Dis; 2007 May; 195(9):1283-93. PubMed ID: 17396997
[TBL] [Abstract][Full Text] [Related]
14. An outbreak of HIV-1 subtype G among Italian injecting drug users.
Ciccozzi M; Montieri S; Salemi M; De Oliveira T; Dorrucci M; Sinicco A; De Luca A; Giuliani M; Balotta C; Rezza G
AIDS; 2007 May; 21(9):1213-5. PubMed ID: 17502735
[TBL] [Abstract][Full Text] [Related]
15. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia.
Tee KK; Saw TL; Pon CK; Kamarulzaman A; Ng KP
AIDS Res Hum Retroviruses; 2005 Dec; 21(12):1046-50. PubMed ID: 16379608
[TBL] [Abstract][Full Text] [Related]
16. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
[TBL] [Abstract][Full Text] [Related]
17. HIV outbreak among injecting drug users in the Helsinki region: social and geographical pockets.
Kivelä P; Krol A; Simola S; Vaattovaara M; Tuomola P; Brummer-Korvenkontio H; Ristola M
Eur J Public Health; 2007 Aug; 17(4):381-6. PubMed ID: 17130140
[TBL] [Abstract][Full Text] [Related]
18. [Human immunodeficiency virus type 1 strains epidemic in Shenzhen].
Feng TJ; Zhao GL; Chen L; Wang XH; Shi XD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):637-41. PubMed ID: 17121221
[TBL] [Abstract][Full Text] [Related]
19. Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: access, adherence and outcomes.
Tyndall MW; McNally M; Lai C; Zhang R; Wood E; Kerr T; Montaner JG
Int J Drug Policy; 2007 Aug; 18(4):281-7. PubMed ID: 17689376
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
